The Zacks Analyst Blog Highlights: AbbVie, Merck, Eli Lilly, Novartis and Pfizer Posted byZacks Equity Research February 7, 2022 Leave a comment on The Zacks Analyst Blog Highlights: AbbVie, Merck, Eli Lilly, Novartis and Pfizer AbbVie, Merck, Eli Lilly, Novartis and Pfizer are included in this analyst blog.